Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Abhilash K Desai & George T Grossberg. (2005) Rivastigmine for Alzheimer’s disease. Expert Review of Neurotherapeutics 5:5, pages 563-580.
Read now
Read now
E. Kapaki & G. P. Paraskevas. (2005) The cognitive effects of cholinesterase inhibitor treatment in every-day practice. Current Medical Research and Opinion 21:6, pages 871-875.
Read now
Read now
Maurizio Recanatini & Andrea Cavalli. (2002) Acetylcholinesterase inhibitors in the context of therapeutic strategies to combat Alzheimer’s disease. Expert Opinion on Therapeutic Patents 12:12, pages 1853-1865.
Read now
Read now
Jay W Pettegrew & Richard J McClure. (2002) Acetyl-l-carnitine as a possible therapy for Alzheimer’s disease. Expert Review of Neurotherapeutics 2:5, pages 647-654.
Read now
Read now
Articles from other publishers (21)
Numan TAŞPINAR & İbrahim BULDUK. (2022) Alternative Analytical Methods for Quantification of Galantamine in PharmaceuticalsFarmasötik Şekillerde Galantamin Miktarının Belirlenmesi İçin Alternatif Analitik Yöntemler. Ege Tıp Bilimleri Dergisi 5:2, pages 58-64.
Crossref
Crossref
Muhammad Nadeem Akram, Robert Verpoorte & Barbora Pomahačová. (2021) Methods for the analysis of galanthamine and its extraction from laboratory to industrial scale. South African Journal of Botany 136, pages 51-64.
Crossref
Crossref
Ana Matošević & Anita Bosak. (2020) Carbamate group as structural motif in drugs: a review of carbamate derivatives used as therapeutic agents. Archives of Industrial Hygiene and Toxicology 71:4, pages 285-299.
Crossref
Crossref
A.A.D.T. Abeysinghe, R.D.U.S. Deshapriya & C. Udawatte. (2020) Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions. Life Sciences 256, pages 117996.
Crossref
Crossref
Yu San Chang, Yu Hsuan Wu, Chin Jen Wang, Shu Hui Tang & Hsiang Lan Chen. (2018) Higher levels of thyroxine may predict a favorable response to donepezil treatment in patients with Alzheimer disease: a prospective, case–control study. BMC Neuroscience 19:1.
Crossref
Crossref
Chih-Hsiang Hsu, Sheue-Er Wang, Ching-Lung Lin, Chun-Jen Hsiao, Shuenn-Jyi Sheu & Chung-Hsin Wu. (2016) Neuroprotective Effects of the Herbal Formula B401 in Both Cell and Mouse Models of Alzheimer’s Disease. Evidence-Based Complementary and Alternative Medicine 2016, pages 1-17.
Crossref
Crossref
Sang Kwang Lee, Min Kyun Park, Ho Eun Jhang, Jinju Yi, Keepyong Nahm, Dae Won Cho, Choon Sup Ra, Kamil Musilek, Anna Horova, Jan Korabecny, Rafael Dolezal, Daniel Jun & Kamil Kuca. (2015)
Preparation of 7-Methoxy Tacrine Dimer Analogs and Their
In vitro/In silico
Evaluation as Potential Cholinesterase Inhibitors
. Bulletin of the Korean Chemical Society 36:6, pages 1654-1660.
Crossref
Crossref
Nibha Mishra & Arijit Basu. (2013) Exploring Different Virtual Screening Strategies for Acetylcholinesterase Inhibitors. BioMed Research International 2013, pages 1-8.
Crossref
Crossref
Erica M. Forsberg, James R. A. Green & John D. Brennan. (2011) Continuous Flow Immobilized Enzyme Reactor–Tandem Mass Spectrometry for Screening of AChE Inhibitors in Complex Mixtures. Analytical Chemistry 83:13, pages 5230-5236.
Crossref
Crossref
D. A. Belinskaya, A. H. Juffer & N. N. Shestakova. (2010) The role of electrostatic interactions in the absorption of ligands to the active sites of cholinesterases, as indicated by molecular modeling data. Russian Journal of Bioorganic Chemistry 36:2, pages 185-190.
Crossref
Crossref
Andrea Lubbe, Barbora PomahacÌováYoung Hae Choi & Robert Verpoorte. (2010) Analysis of metabolic variation and galanthamine content in Narcissus bulbs by 1H NMR. Phytochemical Analysis 21:1, pages 66-72.
Crossref
Crossref
Qianfei Zhao, Guoquan Yang, Xiangdong Mei, Huizhu Yuan & Jun Ning. (2008) Design of novel carbamate acetylcholinesterase inhibitors based on the multiple binding sites of acetylcholinesterase. Journal of Pesticide Science 33:4, pages 371-375.
Crossref
Crossref
Stefan Jaroch. (2007) A Soluble Amyloid Fibril Segment to Study Aggregate Formation. ChemMedChem 2:1, pages 47-49.
Crossref
Crossref
Dong Hyun Kim, Byung Hoon Yoon, Yong-Won Kim, Seungjoo Lee, Bum Young Shin, Ji Wook Jung, Hyoung Ja Kim, Yong Sup Lee, Jae Sue Choi, Sun Yeou Kim, Kyung-Tae Lee & Jong Hoon Ryu. (2007) The Seed Extract of Cassia obtusifolia Ameliorates Learning and Memory Impairments Induced by Scopolamine or Transient Cerebral Hypoperfusion in Mice. Journal of Pharmacological Sciences 105:1, pages 82-93.
Crossref
Crossref
Elisabeth Kapaki, George P. Paraskevas, Emily Mantzou, Apostolos Papapostolou, Maria Alevizaki & Demetris Vassilopoulos. (2006) Thyroid Function in Patients With Alzheimer Disease: Implications on Response to Anticholinesterase Treatment. Alzheimer Disease & Associated Disorders 20:4, pages 242-247.
Crossref
Crossref
Lisa M. Broad, Ruud Zwart, Kathy H. Pearson, Martin Lee, Louise Wallace, Gordon I. McPhie, Renee Emkey, Sean P. Hollinshead, Colin P. Dell, S. Richard Baker & Emanuele Sher. (2006) Identification and Pharmacological Profile of a New Class of Selective Nicotinic Acetylcholine Receptor Potentiators. Journal of Pharmacology and Experimental Therapeutics 318:3, pages 1108-1117.
Crossref
Crossref
Hongxin Dong, Cynthia A. Csernansky, Maureen V. Martin, Amy Bertchume, Dana Vallera & John G. Csernansky. (2005) Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer’s disease. Psychopharmacology 181:1, pages 145-152.
Crossref
Crossref
Andrew G Foley, Helen C Gallagher, Keith J Murphy & Ciaran M Regan. (2004) Pentyl-4-yn-valproic acid reverses age-associated memory impairment in the Wistar rat. Neurobiology of Aging 25:4, pages 539-546.
Crossref
Crossref
Lorna Piazzi, Angela Rampa, Alessandra Bisi, Silvia Gobbi, Federica Belluti, Andrea Cavalli, Manuela Bartolini, Vincenza Andrisano, Piero Valenti & Maurizio Recanatini. (2003)
3-(4-{[Benzyl(methyl)amino]methyl}phenyl)-6,7-dimethoxy-2
H
-2-chromenone (AP2238) Inhibits Both Acetylcholinesterase and Acetylcholinesterase-Induced β-Amyloid Aggregation: A Dual Function Lead for Alzheimer's Disease Therapy
. Journal of Medicinal Chemistry 46:12, pages 2279-2282.
Crossref
Crossref
Judith A. Egan, Richard P. Nugent & Crist N. Filer. (2002) Tritium labelling and characterization of the cognition enhancing drug tacrine using several precursors. Applied Radiation and Isotopes 57:6, pages 837-840.
Crossref
Crossref
Alan M. Palmer. (2002) Pharmacotherapy for Alzheimer's disease: progress and prospects. Trends in Pharmacological Sciences 23:9, pages 426-433.
Crossref
Crossref